前沿论文｜CELL INTELLIGENCE

Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy.

PubMed 2025/01/28 发表Pharmacol ResQ1 · IF 12.2（JCR 2025）

Treatment of Epstein-Barr Virus infection in immunocompromised patients.

PubMed 2024/05/10 发表Biochem PharmacolQ1 · IF 6.5（JCR 2025）

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.

PubMed 2024/02/05 发表J Immunother CancerQ1 · IF 11.7（JCR 2025）

Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer.

PubMed 2023/05/07 发表Cancer SciQ2 · IF 4.9（JCR 2025）

αβ and γδ T-cell responses to Epstein-Barr Virus: insights in immunocompetence, immune failure and therapeutic augmentation in transplant patients.

PubMed 2023/03/22 发表Curr Opin ImmunolQ1 · IF 5.6（JCR 2025）

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies.

PubMed 2023/02/02 发表Front ImmunolQ1 · IF 7（JCR 2025）

这些结果支持将用 ZT002 生成的 gp350CAR-T 细胞作为创新新药，用于治疗实体和血液 EBV 相关恶性肿瘤患者。

PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples.

PubMed 2023/01/01 发表Cancer BiomarkQ4 · IF 1.8（JCR 2025）

PD-L1 在肿瘤细胞和炎症细胞中的表达见于多种人类肿瘤类型。PD-L1 阳性癌症中肿瘤浸润 CD8 阳性淋巴细胞的比例高于 PD-L1 阴性癌症，提示抗肿瘤免疫反应可能触发肿瘤 PD-L1 表达。

Successful treatment of a case with synchronous follicular lymphoma and gastric adenocarcinoma with CD19 CAR T cells and literature review.

PubMed 2022/04/18 发表J Clin Pharm TherQ4 · IF 1.1（JCR 2025）

Immunotherapeutic advances in gastric cancer.

PubMed 2021/02/15 发表Surg TodayQ2 · IF 2.3（JCR 2025）

前沿论文 9